The Fetal Medicine Foundation 20th World Congress in Fetal Medicine, Valencia, Spain
Abstracts
 
  • Aneuploidies
  • cfDNA test
  • Defects
    • Brain
    • Face
    • Heart
    • Lungs
    • Gastrointestinal
    • Abdominal wall
    • Genitourinary
    • Spine
    • Skeleton
    • Hydrops
    • Placenta
    • Other
  • Genetics
    • Exome sequencing
    • Other
  • Artificial placenta
  • Fetal therapy
  • Fetal anemia
  • Congenital infection
    • CMV
    • COVID 19
    • Other
  • Maternal medicine
  • Preeclampsia
  • Gestational diabetes
  • Growth
  • Preterm birth
  • Obstetrics
  • Twins
    • TTTS
    • sFGR
    • TRAP
    • Other
  • Miscellaneous

Preeclampsia

  1. A case of HELLP syndrome at 19+2 weeks of gestation View pdf
  2. Adverse pregnancy outcomes in women at increased risk of preterm preeclampsia View pdf
  3. Angiogenic markers and maternal echocardiographic indices in women with hypertension in pregnancy View pdf
  4. Arterial health abnormalities in women with preeclampsia: contributing role of central obesity View pdf
  5. Arterial health after preeclampsia: role of chronic hypertension View pdf
  6. ASPRE trial: effects of aspirin on mean arterial blood pressure and uterine artery pulsatility index View pdf
  7. ASPRE trial: effects of aspirin on serum PAPP-A and PlGF trajectories in pregnancy View pdf
  8. Association between sFlt-1/PlGF ratio and incidence of intrauterine growth restriction View pdf
  9. Association between sFlt-1/PlGF ratio and incidence of maternal-fetal and neonatal complications View pdf
  10. Association of preeclampsia with demographic characteristics in pregnant women View pdf
  11. Can Pravastatin/L-arginine therapy improve placental perfusion in singleton pregnancies? View pdf
  12. Cardiac function in first trimester in women with preeclampsia View pdf
  13. Cardiac function in women with first trimester risk of preeclampsia: case-control study View pdf
  14. Cerebral Doppler and fetal vasoconstriction: hemodynamics and clinical relevance View pdf
  15. Changes in uterine Doppler and circulating angiogenic factors in the third trimester View pdf
  16. Circulating neutrophil extracellular traps contribute to endothelial dysfunction in preeclampsia View pdf
  17. Clinical effectiveness of routine first-trimester combined screening for preeclampsia View pdf
  18. Endothelial damage and complement dysregulation in fetuses from preeclamptic mothers View pdf
  19. Epidemiology and perinatal outcomes of early-onset preeclampsia View pdf
  20. Evaluation of first trimester maternal serum glycosylated fibronectin for preeclampsia screening View pdf
  21. Evaluation of sFlt-1/PlGF ratio and adverse outcomes in preterm preeclampsia View pdf
  22. Evolution of sFlt-1/PlGF ratio and blood pressure levels in twin pregnancies View pdf
  23. Fetal aortic intima-media thickness measurement as a second-trimester predictor of preeclampsia View pdf
  24. Fetal growth restriction in preeclamptic pregnancy as a predictor of adverse neonatal outcomes View pdf
  25. FMF vs NICE screening for preeclampsia in first trimester View pdf
  26. Glycosylated Fibronectin as point of care test in cases of placental dysfunction View pdf
  27. Home telemonitoring versus hospital care in complicated pregnancies in the Netherlands View pdf
  28. Hypertensive crisis: cardiovascular resistance index for prediction of labetalol response View pdf
  29. Hypertensive disorders of pregnancy after multifetal pregnancy reduction: a meta-analysis View pdf
  30. Long-term risk of chronic arterial hypertension in pregnant women with a history of preeclampsia View pdf
  31. Machine learning approach for the prediction of preeclampsia in a middle-income country View pdf
  32. Maternal and neonatal outcomes in acute fatty liver of pregnancy and HELLP syndrome View pdf
  33. Maternal and perinatal outcomes in users of aspirin as prevention of preterm preeclampsia View pdf
  34. MATERNAL CARDIAC FUNCTION AND GEOMETRY FOR THE PREDICTION OF LATE-PLACENTAL INSUFFICIENCY AT THE BEGINNING OF THIRD-TRIMESTER View pdf
  35. Maternal-fetal medicine program and pregnancy outcomes in severe preeclampsia View pdf
  36. Mid-trimester uterine artery Doppler for aspirin discontinuation View pdf
  37. Myocardial remodelling in chronic arterial hypertension as a predictor of adverse pregnancy outcomes View pdf
  38. Ophthalmic artery Doppler in the complementary diagnosis of preeclampsia: a meta-analysis View pdf
  39. PAPP-A in the first trimester of pregnancy as a predictor of preeclampsia View pdf
  40. Performance of a machine learning approach to predict preterm preeclampsia View pdf
  41. Postpartum PIGF concentration predicts abnormal blood pressure in early puerperium View pdf
  42. Potential biomarkers for late-onset and term preeclampsia View pdf
  43. Prediction and prevention of preeclampsia: Brazilian guidelines 2023 View pdf
  44. Prediction model of hypertensive disorders in pregnancy with the sFlt-1/PlGF ratio View pdf
  45. Prediction of placental dysfunction in pregnancies with systemic lupus erythematosus View pdf
  46. Pregnant women at high risk of preeclampsia and prophylactic aspirin in low resource settings View pdf
  47. Preterm preeclampsia screening: phenotypic biomarker models and robust prediction models View pdf
  48. Role of circulating placenta-derived extracellular vesicles in preeclampsia View pdf
  49. Screening and prevention of preeclampsia: audit and literature review View pdf
  50. Screening for late preeclampsia at 35-38 weeks`gestation View pdf
  51. Stage B heart failure in pregnancies with hypertensive disease in pregnancy View pdf
  52. The association of IL-17 and PlGF/sENG ratio in preeclampsia and adverse pregnancy outcomes View pdf
  53. The fourth trimester clinic: a quality improvement project for preeclamptic patients View pdf
  54. The impact of the implementation of preeclampsia screening in the first trimester View pdf
  55. The value of C-reactive protein in the prediction of preeclampsia View pdf
  56. Urinary congophilia in triaging women with hypertensive disorders of pregnancy View pdf
  57. Uterine artery doppler examination in pregnancies with GDM and pregnancies with GDM and preeclampsia, in the 1st trimester and throughout pregnancy View pdf
463844544539432043194561456245764577561045734605460447494513455143724494437543214864465246334688447356134414468447904803438443444680562643304371560046014411435346634459460247924678438343594493443146814282428442964662445647545627
© 2023 The Fetal Medicine Foundation